UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 30, 2013
ONYX PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
| 000-28298 |
| 94-3154463 |
(State or other |
| (Commission |
| (IRS Employer |
jurisdiction of |
| File Number) |
| Identification No.) |
incorporation) |
|
|
|
|
249 East Grand Avenue South San Francisco, California |
| 94080 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (650) 266-0000
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On June 30, 2013, Onyx Pharmaceuticals, Inc. issued a press release regarding the offer made by Amgen Inc. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. |
| Description |
|
|
|
99.1 |
| Press Release issued by Onyx Pharmaceuticals, Inc. dated June 30, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ONYX PHARMACEUTICALS, INC. | ||
|
|
| |
|
|
| |
Date: July 1, 2013 | By: | /s/ Suzanne M. Shema | |
|
| Name: | Suzanne M. Shema |
|
| Title: | Executive Vice President, General Counsel and Corporate Secretary |